Lumira
Finnrick has tested 64 samples from Lumira across 7 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| GHK-Cu | 11 | 23 Apr 2026 | 5 Aug 2026 | |||||
| Tirzepatide | 10 | 28 Apr 2026 | 18 Aug 2026 | |||||
| NAD+ | 5 | 11 May 2026 | 22 Jul 2026 | |||||
| BPC-157 | 6 | 6 May 2026 | 18 Aug 2026 | |||||
| Retatrutide | 19 | 23 Apr 2026 | 13 Aug 2026 | |||||
| Tesamorelin | 8 | 28 Apr 2026 | 13 Aug 2026 | |||||
| TB-500 | 5 | 11 May 2026 | 9 Aug 2026 | |||||
The Lumira samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 64 overall satisfaction reports
People who submitted test requests to Finnrick gave Lumira an average satisfaction rating of 4.5 out of 5 across 64 reports associated with samples received and tested by Finnrick. Customers rated payment methods (4.1/5) and delivery speed (3.8/5) comparatively lower.
Most recent Lumira tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 18 Aug 2026 | BPC-157 | View | 10mg | ⚠️ Sample does not contain BPC-157 | PPA-WL-BC10-P00704 | No label / Silver crimp / White cap | Lab G | Public | |||
| 18 Aug 2026 | Tirzepatide | View | 20mg | 20.8mg | +4.0% | 99.80% | PPA-WL-TR20-P00714 | No label / Silver crimp / Blue cap | Lab G | Public | |
| 13 Aug 2026 | Tesamorelin | View | 10mg | 13.6mg | +36.0% | 99.60% | WL-TSM10-P00099 | White label, Silver crimp, Black cap | Lab G | Public | |
| 13 Aug 2026 | Retatrutide | View | 10mg | 10.6mg | +6.0% | 99.70% | WL-RT10-P00521 | White label, Silver crimp, Clear Blue cap | Lab G | Public | |
| 9 Aug 2026 | BPC-157 | View | 10mg | 9.1mg | -9.0% | 99.60% | WL-BC10-000299 | No label, Silver crimp, Black cap | Lab G | Public | |
| 9 Aug 2026 | TB-500 | View | 10mg | 8.6mg | -14.0% | 99.50% | WL-TB10-000298 | No label, Silver crimp, Green cap | Lab G | Public | |
| 9 Aug 2026 | Retatrutide | View | 30mg | 25.2mg | -16.0% | 99.90% | WL-RT30-000298 | No label, Silver crimp, Violet cap | Lab G | Public | |
Corrections
- 4 Aug 2026: BPC-157
- The original Certificate of Analysis (COA 209392) incorrectly identified the sample as **Tirzepatide** instead of the correct compound, **BPC-157**. The testing laboratory subsequently reissued the Certificate of Analysis as **COA 209656**, correcting the sample identification. The updated COA has been used to replace the incorrect information.
- 26 Jul 2026: NAD+
- The COA data was corrected from 56.8 to 568 following identification of a probable parsing error during data extraction. As a result of this correction, the calculated score was updated from 3.5 to 4.1.
About Lumira Test Results From Finnrick
Lumira is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 7 products and 64 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Lumira Testing Activity & Score Summary
In the past 30 days, Finnrick has published 15 new test results for Lumira, and 49 in the past three months. The overall dataset includes 64 tested samples with an average score of 6.1/10 across all products.
Across 64 identity-tested samples, 75% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.9%. Approximately 96% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (19 tests, 84% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 2.0 to 10.0 (average 7.1/10), suggesting significant batch-to-batch differences.
- GHK-Cu (11 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 6.0 to 10.0 (average 7.9/10), suggesting significant batch-to-batch differences.
- Tirzepatide (10 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 5.0 to 9.8 (average 7.0/10), suggesting significant batch-to-batch differences.